This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 1990 Sep:25 Suppl 1:S39-41.

doi: 10.1097/00004424-199009001-00018.

Nonionic magnetic resonance imaging contrast agents. Clinical trial experience of safety, tolerance, and efficacy of gadodiamide injection

M Van Wagoner¹, M O'Toole, S C Quay

Affiliations

PMID: 2283251
DOI: 10.1097/00004424-199009001-00018

Clinical Trial

Nonionic magnetic resonance imaging contrast agents. Clinical trial experience of safety, tolerance, and efficacy of gadodiamide injection

M Van Wagoner et al. Invest Radiol. 1990 Sep.

. 1990 Sep:25 Suppl 1:S39-41.

doi: 10.1097/00004424-199009001-00018.

Authors

M Van Wagoner¹, M O'Toole, S C Quay

Affiliation

¹ Salutar, Inc., Sunnyvale, California.

PMID: 2283251
DOI: 10.1097/00004424-199009001-00018

No abstract available

PubMed Disclaimer

Similar articles

A phase I clinical trial with gadodiamide injection, a nonionic magnetic resonance imaging enhancement agent.
VanWagoner M, O'Toole M, Worah D, Leese PT, Quay SC. VanWagoner M, et al. Invest Radiol. 1991 Nov;26(11):980-6. doi: 10.1097/00004424-199111000-00010. Invest Radiol. 1991. PMID: 1743922 Clinical Trial.
Can gadolinium be safely given in renal failure?
Weissleder R. Weissleder R. AJR Am J Roentgenol. 1996 Jul;167(1):278-9. doi: 10.2214/ajr.167.1.8659405. AJR Am J Roentgenol. 1996. PMID: 8659405 No abstract available.
Safety and tolerance after intravenous administration of 0.3 mmol/kg Gd-DTPA. Results of a randomized, controlled clinical trial.
Niendorf HP, Haustein J, Louton T, Beck W, Laniado M. Niendorf HP, et al. Invest Radiol. 1991 Nov;26 Suppl 1:S221-3; discussion S232-5. doi: 10.1097/00004424-199111001-00075. Invest Radiol. 1991. PMID: 1808134 Clinical Trial. No abstract available.
MR contrast enhancement of intracranial lesions with Gd-DTPA.
Hesselink JR, Press GA. Hesselink JR, et al. Radiol Clin North Am. 1988 Jul;26(4):873-87. Radiol Clin North Am. 1988. PMID: 3289078 Review.
Preclinical safety assessment and pharmacokinetics of gadodiamide injection, a new magnetic resonance imaging contrast agent.
Harpur ES, Worah D, Hals PA, Holtz E, Furuhama K, Nomura H. Harpur ES, et al. Invest Radiol. 1993 Mar;28 Suppl 1:S28-43. doi: 10.1097/00004424-199303001-00004. Invest Radiol. 1993. PMID: 8486501 Review.

See all similar articles

Cited by

A double-blind, comparative study of gadodiamide injection and gadopentetate dimeglumine in MRI of the central nervous system.
Valk J, Algra PR, Hazenberg CJ, Slooff WB, Svaland MG. Valk J, et al. Neuroradiology. 1993;35(3):173-7. doi: 10.1007/BF00588486. Neuroradiology. 1993. PMID: 8459913 Clinical Trial.
Evaluation of the clinical safety of gadodiamide injection, a new nonionic MRI contrast medium for the central nervous system: a European perspective.
Aslanian V, Lemaignen H, Bunouf P, Svaland MG, Borseth A, Lundby B. Aslanian V, et al. Neuroradiology. 1996 Aug;38(6):537-41. doi: 10.1007/BF00626092. Neuroradiology. 1996. PMID: 8880714 Clinical Trial.
Contrast-enhanced MRI of the central nervous system: comparison between gadodiamide injection and gadolinium-DTPA.
Akeson P, Jonsson E, Haugen I, Holtås S. Akeson P, et al. Neuroradiology. 1995 Apr;37(3):229-33. doi: 10.1007/BF01578263. Neuroradiology. 1995. PMID: 7603600 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information